Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Myeloid, Acute

Explore clinical trials studying Leukemia, Myeloid, Acute. Study availability and eligibility vary by location and protocol.

2,461 public trials 543 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Myeloid, Acute trial results

Recruiting

Phase I Clinical Study: BG1805 Injection in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia

NCT06118788

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +4 more
Locations
  • ZhuJiang Hospital of Southern Medical University Guangzhou, Guangdong, China
  • Nanfang Hospital of Southern Medical University Guangzhou, Guangdong, China
  • The First Affiliated Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang, China
View Trial Details
Recruiting

Safety and Efficacy of RVU120 Combined With Venetoclax for Treatment of Relapsed/Refractory AML

NCT06191263

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Centre Hospitalier Universitaire Grenoble Alpes Grenoble, France
  • Centre Hospitalier Le Mans Le Mans, France
  • Centre Hospitalier Universitaire De Lille Lille, France
  • Institut Paoli-Calmettes Marseille, France
View all 37 locations
View Trial Details
Recruiting

Micro-transplantation in Elderly Patients With Acute Myeloid Leukemia

NCT03439371

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • CHU Estaing Clermont-Ferrand, France
  • Centre Hospitalier Universitaire de Grenoble Grenoble, France
  • CHRU de Lille Lille, France
  • Centre Hospitalier Lyon Sud Lyon, France
View Trial Details
Recruiting

Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML

NCT06652438

Conditions
Acute Myeloid Leukemia, Adult, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • DE-Berlin-CAMPUSBENFRANKLIN Berlin, Germany
  • DE-Berlin-CAMPUSVIRCHOW Berlin, Germany
  • DE-Berlin-VIVANTESNEUKOLLN Berlin, Germany
  • DE-Bochum-RUB Bochum, Germany
View all 67 locations
View Trial Details
Recruiting

Study Investigating the Efficacy and Safety of the Addition of Oral-azacitidine to Salvage Treatment by Gilteritinib in Subjects ≥18 Years of Age With Relapsed/Refractory FLT3-mutated Acute Myeloid Leukemia

NCT06022003

Conditions
AML, Adult, FLT3-ITD, FLT3-TKD Mutation, +9 more
Locations
  • Amiens CHU Amiens, France
  • Angers CHU Angers, France
  • Hôpital d'Instruction des Armées PERCY Clamart, France
  • CHU Estaing Clermont-Ferrand, France
View all 20 locations
View Trial Details

Related conditions